Paspigioni published an article examining why sponsors are increasingly turning to CROs with deep networks in Central and Eastern Europe, the Caucasus, and Central Asia for trial timelines in oncology and rare disease.
Public source
Publisher name
Public post
Everyone’s talking about decentralized trials. Fewer people are talking about where the sites actually are. In our new article, we look at why sponsors are increasingly…
Company
Paspigioni
Improving patients’ lives
- Industry
- Research Services
- Location
- London, GB
- Company size
- 11–50 employees
About Paspigioni
Paspigioni is a full-service contract research organisation dedicated to excellence in clinical trials of pharmaceutical, biotech, and medical devices. Our comprehensive approach ensures client's receive expert guidance through every phase of clinical trials.
See moreLatest activity
Latest activity from Paspigioni
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Avacare Clinical Research Network
Avacare Clinical Research Network published a pharmaphorum article featuring insights from Avacare's Director of Project Optimization, Kimberly Ponder, sharing five strategies to improve recruitment, retention, and data quality.
Research & Knowledge
Clinical Trials Transformation Initiative (CTTI)
Clinical Trials Transformation Initiative (CTTI) released the Enabling Expedited Pathways booklet as the first deliverable from an ongoing effort to better understand the use of expedited programs for drugs, biologics, and devices.
Research & Knowledge
Worldwide Clinical Trials
Worldwide Clinical Trials published an article examining how urine biomarkers, patient monitoring, and screening logistics help sponsors identify and reach lupus nephritis trials with unpredictable flares and disease activity.
Research & Knowledge
Veeda Lifesciences
Veeda Lifesciences published an article exploring how a strategic approach to virtual investigator meetings can support better clinical trial execution.
Research & Knowledge
Frontier Clinical Trials Ltd